229 related articles for article (PubMed ID: 7448732)
1. Steroid hormone receptors and clinical usefulness in human breast cancer.
Nomura Y; Yamagata J; Takenaka K; Tashiro H
Cancer; 1980 Dec; 46(12 Suppl):2880-3. PubMed ID: 7448732
[TBL] [Abstract][Full Text] [Related]
2. Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer.
Nomura Y; Tashiro H; Shinozuka K
Cancer; 1985 Feb; 55(3):546-51. PubMed ID: 3965108
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy.
Jakesz R; Dittrich C; Hanusch J; Kolb R; Lenzhofer R; Moser K; Rainer H; Reiner G; Schemper M; Spona J
Ann Surg; 1985 Mar; 201(3):305-10. PubMed ID: 3977430
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen and progesterone receptors and response to endocrine therapy in Japanese breast cancer.
Nomura Y; Takatani O; Sugano H; Matsumoto K
J Steroid Biochem; 1980 May; 13(5):565-6. PubMed ID: 7392632
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
Ravdin PM; Green S; Dorr TM; McGuire WL; Fabian C; Pugh RP; Carter RD; Rivkin SE; Borst JR; Belt RJ
J Clin Oncol; 1992 Aug; 10(8):1284-91. PubMed ID: 1634918
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer.
Nordenskjöld A; Fohlin H; Fornander T; Löfdahl B; Skoog L; Stål O
Breast Cancer Res Treat; 2016 Nov; 160(2):313-322. PubMed ID: 27722840
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone receptors: correlation of response rates, site and timing of receptor analysis.
Stewart J; King R; Hayward J; Rubens R
Breast Cancer Res Treat; 1982; 2(3):243-50. PubMed ID: 7150779
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer.
Leclercq G; Heuson JC
Eur J Cancer (1965); 1977 Nov; 13(11):1205-15. PubMed ID: 338304
[No Abstract] [Full Text] [Related]
10. Therapy for cancer of the breast. Current status of steroid hormone receptors.
Osborne CK; McGuire WL
West J Med; 1979 May; 130(5):401-7. PubMed ID: 516664
[TBL] [Abstract][Full Text] [Related]
11. Current status of estrogen and progesterone receptors in breast cancer.
McGuire WL; Horwitz KB; Pearson OH; Segaloff A
Cancer; 1977 Jun; 39(6 Suppl):2934-47. PubMed ID: 326386
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy.
Manni A; Arafah B; Pearson OH
Cancer; 1980 Dec; 46(12 Suppl):2838-41. PubMed ID: 7448730
[TBL] [Abstract][Full Text] [Related]
13. The use of steroïd hormone receptors in the treatment of human breast cancer: a review.
Osborne CK; McGuire WL
Bull Cancer; 1979; 66(3):203-9. PubMed ID: 385079
[TBL] [Abstract][Full Text] [Related]
14. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.
Yu KD; Liu GY; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
Breast; 2007 Jun; 16(3):307-15. PubMed ID: 17293115
[TBL] [Abstract][Full Text] [Related]
16. Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
Dowsett M; Allred C; Knox J; Quinn E; Salter J; Wale C; Cuzick J; Houghton J; Williams N; Mallon E; Bishop H; Ellis I; Larsimont D; Sasano H; Carder P; Cussac AL; Knox F; Speirs V; Forbes J; Buzdar A
J Clin Oncol; 2008 Mar; 26(7):1059-65. PubMed ID: 18227529
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast.
Dao TL; Nemoto T
Cancer; 1980 Dec; 46(12 Suppl):2779-82. PubMed ID: 7448720
[TBL] [Abstract][Full Text] [Related]
18. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
Encarnación CA; Ciocca DR; McGuire WL; Clark GM; Fuqua SA; Osborne CK
Breast Cancer Res Treat; 1993; 26(3):237-46. PubMed ID: 8251648
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Pater JL;
J Clin Oncol; 2007 May; 25(15):2006-11. PubMed ID: 17452676
[TBL] [Abstract][Full Text] [Related]
20. A study on the correlation between estrogen receptor, progesterone receptor and tamoxifen binding sites in human breast cancer tissues.
Imanaka Y; Tsuboi S; Kohno N; Saitoh Y
Jpn J Surg; 1987 Nov; 17(6):487-92. PubMed ID: 3437623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
